Akums Medicines & Pharmaceuticals announced that it has opened a new manufacturing facility and entered the gummies market. According to the company, it seeks to provide treatment for a variety of ailments for adults, children, and elderly patients who are searching for an alternative to traditional dose forms such pills, capsules, syrup, etc. since they no longer find these options easy or palatable. “We are always committed to ensuring that we do not just produce medicines that are effective, but also produce them in formats that are easy to consume. That is what we are aiming to achieve through this segment,” Akums Joint Managing Director Sandeep Jain said in a statement. The global gummies market is expected to grow at a CAGR of 7.3 per cent between 2021 and 2028.

Buy Latest Research Reports